In interviews with news outlets and scientific publications, NCI Director Dr. Anthony Letai discusses NCI’s research priorities, the state of cancer research funding, and the science shaping the future of cancer care.
Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
The Cancer Letter, October 7, 2026
Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
The Cancer Letter, April 10, 2026
Interview with Dr. Anthony Letai
Pharma Boardroom, February 19, 2026